- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05702918
Evaluation of the Course and Effectiveness of Conservative Therapy in Patients With Achilles Tendinopathy
Evaluation of the Course and Effectiveness of Conservative Therapy in Patients With Achilles Tendinopathy Using Ultrasonography
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
This work is designed as a randomized clinical trial, in which the effects of a protocol of 12-week resistance training loading the Achilles tendon and low-energy focused extracorporeal shock wave therapy (ESWT) in patients with Achilles tendinopathy (AT) will be monitored. It is estimated that at least 40 patients will participate, randomly divided into two groups. Group A will be instructed to perform a training protocol in combination with ESWT according to selected parameters. Group B only completes the same training protocol.
The research within one patient will last a total of 26 weeks from the initial to the final examination and will include several control measurements: at 6, 12, and 26 week from the beginning of therapy. Potential participants will be selected based on the recommendation of a specialist doctor and their suitability will be assessed according to the inclusion criteria. They will then be invited to an initial examination. This will include an objective examination by a physiotherapist, a subjective assessment by the patient and an ultrasonographic (USG) examination followed by a micromorphological analysis using special software. At the end of the initial examination, the participant will be randomly assigned to group A or B. The study program for a specific participant will depend on the assigned group.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Prague, Czechia
- University Hospital Motol and 2nd Faculty of Medicine, Charles University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- the patient shows symptoms of Achilles tendinopathy (pain, swelling and dysfunction in the area of Achilles tendon), which at least partially limit his quality of life during normal or sporting activities,
- the patient is in the age group of 18-60 years,
- the patient has difficulties in only one lower limb; the second, asymptomatic limb will be considered the reference,
- the patient is not aware of any mechanical damage to the tendon in symptomatic limb in the past (e.g. partial or complete rupture as a result of an injury),
- the patient has not undergone any treatment aimed at AS in the last 3 months (surgery, corticoid application, plasma therapy, shock waves, physiotherapy, etc.), objective US examination of AS shows structural changes (expansion, neovascularization, focal hypoechoic areas, etc.).
Exclusion Criteria:
- patient has been diagnosed with a rheumatic disease or a disease of the central nervous system
- patient has any condition which is contraindication for ESWT application
- patient is aware of mechanical damage to the Achilles tendon as a result of an injury in the past.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Group B - exercise
Participants in group B will complete a 12-week ankle dorsiflexion resistance training protocol according to Silbernagel.
It is a series of heel rise exercises with a gradual progression of load according to defined criteria, which the patient practices every day.
|
It is a 12-week Silbernagel ankle dorsiflexion resistance training protocol.
It is a series of exercises with a gradual progression of load according to defined criteria, which the patient practices every day.
|
|
Active Comparator: Group A - ESWT + exercise
Participants in group A will complete a 12-week ankle dorsiflexion resistance training protocol according to Silbernagel. It is a series of heel rise exercises with a gradual progression of load according to defined criteria, which the patient practices every day. In addition, participants will receive a low-energy focused ESWT. In total, it will be applied 4 times with an interval of 7 days from the BTL-6000 FSWT device with piezoelectric generator. The energy will be set to 0.10-0.14 mJ/mm2, frequency 5 Hz, total number of shocks 2000. The application will be semi-static at the location of the largest USG finding. Shocks are applied from all three sides (medial, lateral, dorsal). The set values will not change throughout the research. These parameters were selected in accordance to ISMST guidelines. |
It is a 12-week Silbernagel ankle dorsiflexion resistance training protocol.
It is a series of exercises with a gradual progression of load according to defined criteria, which the patient practices every day.
The energy will be set to 0.10-0.14
mJ/mm2, frequency 5 Hz, total number of shocks 2000.
The application will be semi-static at the location of the largest USG finding.
Shocks are applied from all three sides (medial, lateral, dorsal).
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Peak Spatial Frequency Radius at the Site of Pathology
Time Frame: Values at baseline and week 26.
|
Peak Spatial Frequency Radius (PSFR) was assessed using spatial frequency analysis (SFA) software applied to standardized B-mode ultrasound images of the Achilles tendon. Ultrasound images were acquired in a long-axis using predefined machine settings. The image was saved and exported for subsequent analysis. In the SFA software, the region corresponding to the site of maximal tendon pathology was selected, and PSFR values (mm-¹) were calculated. PSFR values were recorded at baseline and at the 26-week follow-up. |
Values at baseline and week 26.
|
|
VISA-A Questionnaire Score
Time Frame: Values at baseline and week 26.
|
The VISA-A questionnaire is a validated, disease-specific patient-reported outcome measure for Achilles tendinopathy. Scores range from 0 to 100 (score on scale), with higher scores indicating better function and fewer symptoms. Scores were recorded at baseline and at the 26-week follow-up. |
Values at baseline and week 26.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Tendon Diameter at the Place of Maximum Tendon Width
Time Frame: Values at baseline and week 26.
|
Achilles tendon diameter was measured using standardized B-mode ultrasound imaging at the site of maximal tendon width. Measurements were performed using built-in ultrasound system measurement tools. Measurements were recorded at baseline and at the 26-week follow-up. |
Values at baseline and week 26.
|
|
Pain Intensity Measured by Numeric Rating Scale (NRS)
Time Frame: Values at baseline and week 26
|
Pain intensity was assessed using an 11-point Numeric Rating Scale (NRS), ranging from 0 (no pain) to 10 (worst imaginable pain). Scores were recorded at baseline and at the 26-week follow-up. |
Values at baseline and week 26
|
Collaborators and Investigators
Sponsor
Investigators
- Study Chair: Stanislav Machac, PhD, University Hospital Motol and 2nd Faculty of Medicine, Charles University
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- EK-402 /22
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Achilles Tendinopathy
-
Women's College HospitalUniversity Health Network, Toronto; Unity Health Toronto; University of Toronto; The Physicians' Services Incorporated FoundationNot yet recruitingAchilles Tendinopathy | Achilles Insertional TendinopathyCanada
-
University of CalgarySport Science Association of Alberta (SSAA)UnknownAchilles Tendinopathy | Achilles Tendon Enthesopathy | Mid-Portion Achilles Tendinopathy | Insertional Achilles Tendinopathy | Non-Insertional Achilles TendinopathyCanada
-
Cardenal Herrera UniversityCompletedAchilles TendinopathySpain
-
KU LeuvenUniversitaire Ziekenhuizen KU LeuvenRecruitingAchilles Tendinopathy (AT)Belgium
-
Krankenhaus Barmherzige Schwestern LinzActive, not recruitingAchilles Tendinopathy | Insertional Achilles TendinopathyAustria
-
Spaulding Rehabilitation HospitalStorz Medical AG; Foundation for Physical Medicine and RehabilitationNot yet recruitingAchilles Tendon Pain | Achilles Injuries Tendon | Achilles Tendonitis | Achilles Tendinitis, Right Leg | Achilles Tendinitis, Left Leg | Achilles Tendinopathy (AT)United States
-
Universidad de ZaragozaRecruiting
-
Joint & Vascular InstituteRecruiting
-
Riphah International UniversityCompletedEffects of Tissue Flossing on Pain and Functional Performance in Patients With Achilles TendinopathyAchilles Tendinopathy (AT)Pakistan
-
Ankara City Hospital BilkentCompletedAchilles Tendinopathy (AT)Turkey (Türkiye)
Clinical Trials on Achilles Tendon Loading Exercise Protocol According to Silbernagel
-
University Hospital, MotolWithdrawnAchilles TendinopathyCzechia